Study: Latent CMV in Sperm May Cause Male Infertility; polyDNA Recommends Gene-Eden-VIR against the Latent Human Cytomegalovirus

Study: Latent CMV in Sperm May Cause Male Infertility; polyDNA Recommends Gene-Eden-VIR against the Latent Human Cytomegalovirus

Rochester, NY (PRWEB) April 03, 2014

The human cytomegalovirus (CMV) may be a cause of male infertility. In fact, “15-20% of infertile subjects are affected by semen infection (1).” Even if a man has no symptoms, he may have a latent infection in his sperm. In addition, this type of infection is associated with poor sperm quality (1). polyDNA therefore recommends that men ask their doctors for a blood test that identifies the existence of a latent infection with CMV. If positive, that individual should then speak to their doctors about Gene-Eden-VIR. This natural antiviral was designed to help the immune system target the latent CMV.

Researchers believe that latent viral infections are an underestimated etiological factor in male infertility (1). In other words, doctors often take the existence of a latent viral infection too lightly. As study authors wrote, “common sexually transmitted viruses are able to colonize semen, and thus, (should be) of major concern for reproductive specialists are (the) herpesviruses (HSV), human cytomegalovirus (CMV), and adeno-associated virus (AAV) (1).”

For example, CMV is able to infect most parts of a man’s sperm. “A recent study on HCMV-infected organotypic cultures identified the presence of viral antigens and viral particles in spermatogonia, spermatocytes, and in spermatids, producing lytic effects.” In other words, the virus began to actively replicate in all stages of sperm development.

Study authors noted that a latent infection with CMV can harm a man’s ability to reproduce, by affecting sperm parameters and function. Additionally, it can be transmitted to both mothers and babies in the uterus, causing potentially life-threatening conditions, especially for newborns (1).

“Several drugs are approved for the treatment of HCMV infections in immunocompromised individuals. These drugs include ganciclovir, its oral prodrug valganciclovir, cidofovir, foscavir, and fomivirsen. However, the use of these drugs in immunocompetent individuals is limited by their toxicity, poor oral bioavailability, modest efficacy, and the development of drug resistance.” (See Pharmacology & Pharmacy, from September 2013) (2). There are also some natural antivirals like Gene-Eden-VIR.

“We recommend that individuals concerned about infertility get tested for the presence of a latent CMV infection. If positive, that person should talk to the doctor about Gene-Eden-VIR.” – Mike Evans, polyDNA

A study published on August 12, 2013 in the peer reviewed, medical journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs, showed that Gene-Eden-VIR reduced herpes symptoms. Study authors wrote that, “Individuals infected with the herpes virus… reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR (2).” The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms (2).”

Research shows that an infection with CMV also causes a feeling of physical and mental fatigue. Since Gene-Eden-VIR is antiviral, a second post-marketing clinical study showed that Gene-Eden-VIR decreases the feeling of physical and mental fatigue. That study was published in March, 2014 in the journal Pharmacology & Pharmacy (3).

To read the study on the antiviral nature of Gene-Eden-VIR, visit:

To read the study on Gene-Eden-VIR’s effects on reducing physical and mental fatigue, visit:

To learn more about Gene-Eden-VIR, and the herpes virus, visit All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.


(1) Sperm viral infection and male infertility: focus on HBV, HCV, HIV, HPV, HSV, HCMV, and AAV. Published in November 2013.

(2) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.

(3) Gene-Eden-VIR Decreased Physical and Mental Fatigue in a Post Marketing Clinical Study That Followed FDA Guidelines; Results Support Microcompetition Theory. Published in March, 2014.

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.

Vocus©Copyright 1997-, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Leave a Reply

You must be logged in to post a comment.

Custom Search
Information contained in this website is not intended to diagnose, treat, cure nor prevent any disease, diagnose health problems or take the place of medical advice. This data is for information only. None of the statements or data in this website has been evaluated or reviewed by the FDA. Be sure to check with your health care practitioner before utilizing any information contained on this website. No claims are made for the accuracy, efficacy or safety of any information on this website. All information is provided "as is" and is to be used at your own risk.,Inc.
Extend your life
Puritan's Pride Offer Banner
Health to Happiness